"Esophageal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the ESOPHAGUS.
| Descriptor ID |
D004938
|
| MeSH Number(s) |
C04.588.274.476.205 C04.588.443.353 C06.301.371.205 C06.405.117.430 C06.405.249.205
|
| Concept/Terms |
Esophageal Neoplasms- Esophageal Neoplasms
- Esophageal Neoplasm
- Neoplasm, Esophageal
- Esophagus Neoplasm
- Esophagus Neoplasms
- Neoplasm, Esophagus
- Neoplasms, Esophagus
- Neoplasms, Esophageal
Cancer of Esophagus- Cancer of Esophagus
- Cancer of the Esophagus
- Esophagus Cancer
- Cancer, Esophagus
- Cancers, Esophagus
- Esophagus Cancers
- Esophageal Cancer
- Cancer, Esophageal
- Cancers, Esophageal
- Esophageal Cancers
|
Below are MeSH descriptors whose meaning is more general than "Esophageal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Esophageal Neoplasms".
This graph shows the total number of publications written about "Esophageal Neoplasms" by people in this website by year, and whether "Esophageal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 3 | 5 |
| 1999 | 2 | 1 | 3 |
| 2000 | 2 | 1 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 1 | 4 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 2 | 4 |
| 2006 | 8 | 0 | 8 |
| 2007 | 4 | 1 | 5 |
| 2008 | 4 | 1 | 5 |
| 2009 | 9 | 1 | 10 |
| 2010 | 5 | 1 | 6 |
| 2011 | 8 | 0 | 8 |
| 2012 | 16 | 0 | 16 |
| 2013 | 13 | 6 | 19 |
| 2014 | 13 | 1 | 14 |
| 2015 | 20 | 2 | 22 |
| 2016 | 15 | 2 | 17 |
| 2017 | 10 | 2 | 12 |
| 2018 | 21 | 0 | 21 |
| 2019 | 16 | 0 | 16 |
| 2020 | 14 | 0 | 14 |
| 2021 | 12 | 1 | 13 |
| 2022 | 16 | 1 | 17 |
| 2023 | 8 | 1 | 9 |
| 2024 | 12 | 2 | 14 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Esophageal Neoplasms" by people in Profiles.
-
SOX2 regulates foregut squamous epithelial homeostasis and is lost during Barrett's esophagus development. J Clin Invest. 2025 Aug 15; 135(16).
-
Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial. Mol Cancer. 2025 Jun 11; 24(1):175.
-
A Simple, Interpretable Machine Learning Model Based on Clinical Factors Accurately Predicts Incident Dysplasia or Malignancy in Barrett's Esophagus. Dig Dis Sci. 2025 Aug; 70(8):2739-2749.
-
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study. ESMO Open. 2025 Feb; 10(2):104107.
-
Defining the Optimal Radiation-induced Lymphopenia Metric to Discern Its Survival Impact in Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2025 May 01; 122(1):31-42.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population. Am J Gastroenterol. 2024 Nov 26; 120(7):1511-1520.
-
Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data. ESMO Open. 2024 Nov; 9(11):103934.
-
A High-Resolution Microendoscope Improves Esophageal Cancer Screening and Surveillance: Implications for Underserved Global Settings Based on an International Randomized Controlled Trial. Gastroenterology. 2025 Mar; 168(3):496-507.e3.
-
Comparative Outcomes and Toxicity in Patients With Esophageal Cancer After Trimodality Therapy With Step-and-Shoot Intensity-Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy: The MD Anderson Experience. Clin Oncol (R Coll Radiol). 2025 Feb; 38:103668.